Skip to main content

Table 1 Search strategy

From: Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses

Search term

 1. Immunotherapy/

 2. immunotherap*.ti,ab.

 3. immuno therap*.ti,ab.

 4. immuno-oncology.ti,ab.

 5. immunooncology.ti,ab.

 6. immuno oncology.ti,ab.

 7. immuno-therap*.ti,ab.

 8. chemoimmunotherap*.ti,ab.

 9. chemo-immunotherap*.ti,ab

 10. checkpoint inhibitor*.ti,ab.

 11. check-point inhibitor*.ti,ab.

 12. check point inhibitor*.ti,ab.

 13. check-point block*.ti,ab.

 14. checkpoint block*.ti,ab.

 15. check point block*.ti,ab.

 16. check-point therap*.ti,ab.

 17. checkpoint therap*.ti,ab.

 18. check point therap*.ti,ab.

 19. pd-l1.ti,ab.

 20. pd-1.ti,ab.

 21. ctla-4.ti,ab.

 22. exp CTLA-4 Antigen/

 23. Cytotoxic T-Lymphocyte Associated Antigen 4.ti,ab.

 24. Cytotoxic T-Lymphocyte Antigen 4.ti,ab.

 25. exp Programmed cell death 1 receptor/

 26. Programmed cell death 1 receptor.ti,ab.

 27. Programmed cell death 1 protein.ti,ab.

 28. Pd 1 protein.ti,ab.

 29. PDCD1 protein.ti,ab

 30. CD279 antigen.ti,ab.

 31. nivolumab.ti,ab.

 32. Opdivo.ti,ab.

 33. pembrolizumab.ti,ab.

 34. Keytruda.ti,ab.

 35. durvalumab.ti,ab.

 36. Imfinzi.ti,ab.

 37. tremelimumab.ti,ab.

 38. Exp ipilimumab/

 39. Yervoy.ti,ab.

 40. atezolizumab.ti,ab.

 41. Tecentriq.ti,ab.

 42. avelumab.ti,ab.

 43. Bavencio.ti,ab.

 44. Economics/

 45. exp Costs and Cost Analysis/

 46. Economics, Medical/

 47. Economics, Nursing/

 48. Economics, Pharmaceutical/

 49. exp Economics, Hospital/

 50. exp “Fees and Charges”/

 51. exp Budgets/

 52. economic*.ti,ab.

 53. cost*.ti,ab.

 54. pric*.ti,ab.

 55. fees.ti,ab.

 56. pharmacoeconomic.ti,ab.

 57. pharmaco-economic.ti,ab.

 58. expendit*.ti,ab.

 59. (value adj2 mone*).ti,ab.

 60. exp models, economic/

 61. exp Neoplasms/

 62. cancer*.ti,ab.

 63. neoplas*.ti,ab.

 64. tumor.ti,ab.

 65. tumor.ti,ab.

 66. malignan*.ti,ab.

 67. or/1–43

 68. or/44–60

 69. or/61–66

 70. 67 and 68 and 69